Clinical trial

Alpha-lipoic Acid in Diabetic Patients With Ischemic Cardiomyopathy

NCT06056687

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2023-03-01

PhaseNA

Study timeline

Study start (actual)2023-03-01Date precision: day

Registry last updated2024-02-21

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Ischemic Cardiomyopathyunresolved

Diabetes Mellitusunresolved

Interventions

Alpha Lipoic Acid 600 MG Oral TabletDRUG · verified · RxNorm: thioctic acid 600 MG Oral Tablet

Placebo TabletOTHER

Sponsors & collaborators

Damanhour Universitylead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06056687 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.